Iradimed (NASDAQ:IRMD – Get Free Report) posted its quarterly earnings results on Thursday. The medical equipment provider reported $0.40 EPS for the quarter, missing the consensus estimate of $0.45 by ($0.05), Zacks reports. Iradimed had a net margin of 26.12% and a return on equity of 23.99%. Iradimed updated its Q1 2025 guidance to 0.390-0.430 EPS and its FY 2025 guidance to 1.710-1.810 EPS.
Iradimed Price Performance
IRMD stock traded down $4.60 on Thursday, reaching $55.88. The company’s stock had a trading volume of 64,905 shares, compared to its average volume of 40,534. The firm has a fifty day moving average of $57.16 and a two-hundred day moving average of $52.02. The company has a market capitalization of $708.00 million, a P/E ratio of 38.35 and a beta of 0.82. Iradimed has a 52 week low of $40.18 and a 52 week high of $63.29.
Insider Buying and Selling at Iradimed
In other Iradimed news, CFO John Glenn sold 2,500 shares of the firm’s stock in a transaction dated Monday, December 2nd. The shares were sold at an average price of $54.18, for a total transaction of $135,450.00. Following the transaction, the chief financial officer now owns 4,383 shares of the company’s stock, valued at approximately $237,470.94. This trade represents a 36.32 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 37.10% of the stock is owned by company insiders.
Wall Street Analyst Weigh In
Check Out Our Latest Research Report on IRMD
About Iradimed
IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. It also provides a non-magnetic Intravenous infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Winter Springs, FL.
Read More
- Five stocks we like better than Iradimed
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Archer Aviation Lands BlackRock Investment—What’s Next for ACHR?
- Are Penny Stocks a Good Fit for Your Portfolio?
- Buffett Buys More Occidental Petroleum—Sticking to His Playbook
- What is the Dow Jones Industrial Average (DJIA)?
- CVS Health: Earnings Beat Ignites Stock Rally
Receive News & Ratings for Iradimed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Iradimed and related companies with MarketBeat.com's FREE daily email newsletter.